Daniel Kantor

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy

Nanomaterials in Antibacterial Photodynamic Therapy and Antibacterial Sonodynamic Therapy

Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis

Fingolimod First-Dose Effects In Patients With Relapsing-Remitting Multiple Sclerosis Concomitantly Treated With Serotonin-Specific Reuptake Inhibitors (P7.233)